In this review, we provide a framework for clinical decision-making in the treatment of differentiated thyroid cancer. The clinical discussion and treatment recommendations are relevant to an adult population (more than 16
Thom R. Loree, MD, FACS
Advertisement
Articles by Thom R. Loree, MD, FACS
Advertisement
Latest Updated Articles
- Differentiated Thyroid Carcinoma: Risk Group Assignment and Management Controversies
Published: January 1st 1998 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
How Can Cellular Therapies Become More Affordable Across the World?
5
